PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
17.83%
Net income growth under 50% of ZETA's 40.68%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-1.12%
Both reduce yoy D&A, with ZETA at -1.61%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-167.19%
Negative yoy working capital usage while ZETA is 0.00%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-167.19%
Negative yoy usage while ZETA is 100.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
392.94%
Some yoy increase while ZETA is negative at -192.80%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-16.76%
Negative yoy CFO while ZETA is 20.83%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-27.36%
Negative yoy CapEx while ZETA is 14.14%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
34.64%
Purchases growth of 34.64% while ZETA is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
No Data
No Data available this quarter, please select a different quarter.
-1759.09%
Both yoy lines negative, with ZETA at -39.54%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-9.40%
Both yoy lines negative, with ZETA at -18.84%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
-20.89%
Negative yoy issuance while ZETA is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
46.83%
We have some buyback growth while ZETA is negative at -23.83%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.